In contrast, ACHN cells, SETD2-competent RCC cells, mainly exhibited the ATG12-immunoreactive band corresponding to the ATG5–ATG12 conjugate but not free ATG12 (Fig. 3a). The gene discussed is SETD2; the disease is renal cell carcinoma.